LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 118 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $42,000 | -92.2% | 10,688 | -90.5% | 0.00% | -90.0% |
| Q3 2021 | $539,000 | -20.9% | 112,120 | -24.4% | 0.03% | -18.9% |
| Q2 2021 | $681,000 | -29.1% | 148,302 | -9.4% | 0.04% | -32.7% |
| Q1 2021 | $961,000 | +45.6% | 163,669 | -15.1% | 0.06% | +14.6% |
| Q4 2020 | $660,000 | +22.2% | 192,890 | -48.6% | 0.05% | +166.7% |
| Q3 2020 | $540,000 | -19.2% | 375,163 | +12.1% | 0.02% | +5.9% |
| Q2 2020 | $668,000 | +106.8% | 334,711 | +102.0% | 0.02% | +88.9% |
| Q1 2020 | $323,000 | +348.6% | 165,711 | +595.2% | 0.01% | +800.0% |
| Q3 2019 | $72,000 | – | 23,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |